PHA-4 responses to nucleolar stress. a Nile Red staining of fixed worms. Synchronized smg-1(cc546);pha-4(zu225) eggs were hatched in M9 buffer to L1 worms at 24 ℃. Subsequently, L1 worms were transferred to NGM plates, raised at 20 ℃, and then collected when they reached 1 day of adulthood for analysis of lipid contents. Representative animals; the anterior is indicated on the left and the posterior is indicated on the right. Scale bar represents 20 μm. b Distribution of the lipid droplet size (% lipid droplets) as measured by Nile Red staining of fixed worms from a. Data are presented as the means ± SD of 10 animals for each worm strain. Significant difference between WT and a specific worm strain, ANOVA, ***P < 0.001. NS, no significant difference. c, d Percentage of triacylglycerol (% TAG) in total lipids (TAG + phospholipids, PL) analyzed by TLC/GC. Data are presented as the means ± SD of four biological repeats. Significant difference between WT and a specific worm strain, Student’s t-test, ***P < 0.001. NS, no significant difference. e Relative mRNA expression of pha-4 in WT and mutant worms. Data are presented as the means ± SD of three biological repeats. Significant difference between WT and a specific worm strain, ANOVA, ***P < 0.001, *P < 0.05. f Confocal microscopy of PHA-4::GFP {wgIs37[pha-4::GFP]} in WT, rrp-8(kun54), rsks-1(ok1255), and AD-treated worms at 1 day of adulthood. BF, bright field. Representative animals; the anterior is indicated on the left and the posterior is indicated on the right. Scale bar represents 10 μm. g Quantification of the fluorescence intensity of PHA-4::GFP from f. Data are presented as the means ± SD of at least 20 worms for each worm strain. Significant difference between WT and rrp-8(kun54) mutant background, ANOVA, ***P < 0.001. h Immunoblotting of PHA-4::GFP {wgIs37[pha-4::GFP]} with anti-GFP antibody in WT, rrp-8(kun54), rsks-1(ok1255), and AD-treated background worms at 1 day of adulthood. WT worms without GFP was used as a negative control and WT worms with PHA-4a::GFP {kunEx136[Pvha-6::pha-4a::GFP]} as a positive control. The relative protein levels of PHA-4::GFP were labeled